Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors

Clinical trial NCT03491631 · UNKNOWN

Trial details

NCT number: NCT03491631
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Tumor, Solid Cancer, Metastatic Neoplasm Malignant

Start date: 2018-11-20
Primary completion: 2023-06-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.